The association between c-fosand c-jun expression and estrogen and progesterone receptors is lost in human endometrial cancer

Tumor Biology

Volumn 20, Issue 4, 1999, Pages 202-211

  Salmi, A ^a   Carpen O ^b   Rutanen, E M ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

C fos; C jun; Endometrial cancer; Ki 67; Steroid receptor

Indexed keywords

ESTROGEN RECEPTOR; HORMONE; KI 67 ANTIGEN; MESSENGER RNA; ONCOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN C FOS;

ARTICLE; CANCER GRADING; CANCER HORMONE THERAPY; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C FOS; ONCOGENE C JUN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; CHEMISTRY; ENDOMETRIUM TUMOR; ESTROGEN THERAPY; GENETICS; MIDDLE AGED; ONCOGENE;

ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENES, FOS; GENES, JUN; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER;

EID: 0032587281     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030064     Document Type: Article

References (30)

1. Murphy LJ: General review: Growth factors and steroid hormone action in endometrial cancer. J Steroid Biochem Mol Biol 1994;48: 419-423.
2. Creasman WT, Soper JT, McCarty KS, McCarty KS, Hinshaw W, Clarke-Pearson DL: Influence of cytoplasmic steroid receptor content on prognosis at early stage endometrial carcinomata. Am J Obstet Gynecol 1985;151:922-932.
3. Geisinger KR, Homesley HD, Morgan TM, Kute TE, Marshall RB: Endometrial adenocarcinoma: A multiparameter clinicopathological analysis including the DNA profile and sex steroid hormone receptors. Cancer 1986;58:1518-1525.
4. Fu YS, Gambone JC, Berek JS: Pathophysiology and management of endometrial hyperplasia and carcinoma. West J Med 1990;153:50-61.
5. Weisz A, Rosales R: Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res 1990;18:5097-5106.
6. Landers JP, Spelsberg TC: New concepts in steroid hormone action: Transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit Rev Eukaryot Gene Expr 1992; 2:19-63.
7. Colotta F, Polentarutti N, Sironi M, Mantovani A: Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 1992;267:18278-18283.
8. Schuchard M, Landers JP, Punkay Sandhu N, Spelsberg TC: Steroid hormone regulation of nuclear proto-oncogenes. Endocr Rev 1993;14: 659-667.
9. Fujimoto H, Hori M, Ichigo S, Nishigaki M, Tamaya T: Tissue differences in the expression of mRNAs of ha-ras, c-myc, fos and jun in human uterine endometrium, myometrium and leiomyoma under the influence of estrogen/progesterone. Tumor Biol 1994;15:311-317.
10. Hyder SM, Nawaz B, Chiappetta C, Yokoama K, Stancel GM: The protooncogene c-jun contains an unusual estrogen-inducible enhancer element within the coding sequence. J Biol Chem 1995;170:8506-8513.
11. Curran T, Franza BR Jr: Fos and Jun: The AP-1 connection. Cell 1988;55:395-397.
12. Salmi A, Heikkilä P, Lintula S, Rutanen E-M: Cellular localization of c-jun mRNA and protein and their relation to the proliferation marker Ki-67 in the human endometrium. J Clin Endocrinol Metab 1998;83: 1788-1796.
13. Sakakibara K, Kan NC, Satyaswaroop PG: Both 17β-estradiol and tamoxifen induce c-fos messenger ribonucleic acid expression in human endometrial carcinoma grown in nude mice. Am J Obstet Gynecol 1992;166:206-212.
14. Fujimoto J, Hori M, Ichigo S, Morishita S, Tamaya T: Clinical implication of fos and jun expressions and protein kinase activity in endometrial cancers. Eur J Gynaecol Oncol 1995;16:138-146.
15. Fujimoto J, Hori M, Ichigo S, Morishita S, Tamaya T: Estrogen induces expression of c-fos and c-jun via activation of protein kinase C in an endometrial cancer cell line and fibroblasts derived from human uterine endometrium. Gynecol Endocrinol 1996;10:109-118.
16. Alkhalaf M, Murphy LJ, Murphy LC: Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells. Mol Endocrinol 1993;7:1634-1641.
17. Bamberger A-M, Bamberger CM, Gellersen B, Schulte HM: Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc Natl Acad Sci USA 1996;93:6169-6174.
18. Kaina B, Haas S, Kappes H: A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs. Cancer Res 1997;57:2721-2731.
19. Koshiyama, M, Konishi I, Nanbu K, Nanbu Y, Mandai M, Komatsu T, Yamoto S, Mori T, Fuji S: Immunohistochemical localization of heat shock proteins HSP70 and HSP90 in the human endometrium: Correlation with sex steroid receptors and Ki-67 antigen expression. J Clin Endocrinol Metab 1995;80:1106-1112.
20. Nielsen AL, Nyholm HCJ: Proliferative activity as revealed by Ki-67 in uterine adenocarcinoma of endometrioid type: Comparison of tumours from patients with and without previous oestrogen therapy. J Pathol 1993;171:199-205.
21. Nordström B, Strang P, Bergström R, Nilsson S, Tribukait B: A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Cancer 1996;78:1942-1951.
22. Salmi A, Rutanen E-M: C-fos and c-jun expression in human endometrium and myometrium. Mol Cell Endocrinol 1996;117:233-240.
23. Barbu V, Dautry F: Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res 1989;17:7115.
24. van Straaten F, Müller R, Curran T, van Beveren C, Verma IM: Complete nucleotide sequence of a human c-onc gene: Deduced amino acid sequence of the human c-Fos protein. Proc Natl Acad Sci USA 1983;80:3183-3187.
25. Hattori K, Angel P, Le Beau MM, Karin M: Structure and chromosomal localization of the functional intronless human JUN protooncogene. Proc Natl Acad Sci USA 1988; 85:9148-9152.
26. Salmi A, Ämmälä M, Rutanen E-M: Proto-oncogenes c-jun and c-fos are down-regulated in human endometrium during pregnancy: Relationship to oestrogen receptor status. Mol Hum Reprod 1996;2:979-984.
27. Shemshedini L, Knauthe R, Sassone-Corsi P, Pronon A, Gronemeyer H: Cell-specific inhibitory and stimulatory effects of FOS and JUN on transcription activation by nuclear receptors. EMBO J 1991;10: 3839-3849.
28. Ambrosino C, Cicatiello L, Cobelis G, Addeo R, Sica V, Bresciani F, Weisz A: Functional antagonism between the estrogen receptor and FOS in the regulation of c-fos protooncogene transcription. Mol Endocrinol 1993;7:1472-1482.
29. Salmi A, Pakarinen P, Peltola A-M, Rutanen E-M: The effect of intra-uterine levonorgestrel use on the expression of C-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium. Mol Hum Reprod, in press.
30. Hunter T: Cooperation between oncogenes. Cell 1991;64:249-270.